Company intelligence / Profile preview

Allergan

Ownership: Public · ABBV
Employees: ~50000
Development stage: Phase 3

Overview

Allergan develops, manufactures, and markets a portfolio of leading aesthetics brands and products including facial injectables, body contouring, plastics, and skin care. Their most notable product is Botox, which generated $2.2 billion in revenue in 2017[6].

Therapeutic areas: GastroenterologyMen's HealthOphthalmologyDermatologyWomen's HealthNeurologyInfectious Diseases
Modalities: Branded pharmaceuticalsbiosimilarsover-the-counter pharmaceutical products
Industry: Pharma

Drug pipeline

122 assets

botulinum neurotoxin

Approved

121 more assets in the full pipeline.

Request access →

Partnerships

Pfizer (attempted $160 billion merger in 2015 that failed)

Financials

Market cap: $439.7B
Total revenue: $17B
Enterprise value: $503.9B

Beyond the preview

Go deeper on Allergan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allergan.

Explore the full profile